RF:EURONEXT PARISEurazeo SE Analysis
Data as of 2026-07-08 - not real-time
$30.59
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Regions Financial is trading above its short‑ and medium‑term moving averages, with a bullish MACD crossover and an RSI perched in the upper‑mid range, suggesting continued momentum but also hinting at near‑term overbought conditions.
The stock’s price sits near a key resistance level around $31, while a solid support zone just above $28 provides a cushion against downside. Fundamentally, the bank delivers a respectable dividend yield of roughly three and a half percent, a payout ratio under 45%, and earnings growth in the high single‑digits, positioning it as a modest value play. Recent earnings beat, despite a slight revenue miss, reinforces resilience, but the DCF‑derived fair value sits below current pricing, indicating limited upside. Overall, the blend of steady cash flow, attractive yield, and a defensive beta below one supports a cautiously optimistic stance, though short‑term technical overextension tempers enthusiasm.
The stock’s price sits near a key resistance level around $31, while a solid support zone just above $28 provides a cushion against downside. Fundamentally, the bank delivers a respectable dividend yield of roughly three and a half percent, a payout ratio under 45%, and earnings growth in the high single‑digits, positioning it as a modest value play. Recent earnings beat, despite a slight revenue miss, reinforces resilience, but the DCF‑derived fair value sits below current pricing, indicating limited upside. Overall, the blend of steady cash flow, attractive yield, and a defensive beta below one supports a cautiously optimistic stance, though short‑term technical overextension tempers enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical resistance with RSI in overbought territory
- Bullish MACD supports short‑term momentum
- Decreasing volume may signal waning buying pressure
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable dividend yield and moderate payout ratio
- Fundamental earnings growth outpacing peers
- Valuation still modestly above DCF fair value, limiting upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistent profitability and solid operating margins
- Lower‑than‑market beta provides defensive characteristics
- Attractive dividend and sustainable cash flow underpin long‑term returns
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin31.00%
P/E Ratio12.6
ROE11.89%
ROA1.39%
P/B Ratio1.5
Op. Cash Flow$2.0B
Industry P/E17.7
Technical Analysis
TrendBullish
RSI66.5
Support$28.10
Resistance$31.04
MA 20$29.45
MA 50$28.41
MA 200$27.20
MACDBullish
VolumeDecreasing
Fear & Greed Index88.86
Valuation
Fair Value$25.86
Target Price$31.67
Upside/Downside3.53%
GradeOvervalued
TypeValue
Dividend Yield3.48%
Risk Assessment
Beta0.80
Volatility22.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.